arsenic has been researched along with Congenital Hypocupremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acar, V; Bénazeth, S; Chaumeil, JC; Corriol, O; Curis, E; Deschamps, P; Guyon, F; Nicolis, I; Zerrouk, N | 1 |
| De Groot, CJ; Monnens, LA; Niermeijer, MF; Nooijen, JL; Van den Hamer, CJ; Willemse, J | 1 |
2 other study(ies) available for arsenic and Congenital Hypocupremia
| Article | Year |
|---|---|
XAS applied to pharmaceuticals: drug administration and bioavailability.
Topics: Arsenic Trioxide; Arsenicals; Biological Availability; Chemistry, Pharmaceutical; Hair; Histidine; Humans; Leukemia, Promyelocytic, Acute; Menkes Kinky Hair Syndrome; Organometallic Compounds; Oxides; Parenteral Nutrition; Spectrometry, X-Ray Emission; Synchrotrons; Zinc | 2001 |
Trace element studies in three patients and a fetus with Menkes' disease. Effect of copper therapy.
Topics: Arsenic; Brain Diseases, Metabolic; Cadmium; Cobalt; Copper; Edetic Acid; Female; Fetal Diseases; Humans; Infant; Iron; Male; Menkes Kinky Hair Syndrome; Mercury; Molybdenum; Pregnancy; Selenium; Tissue Distribution; Trace Elements; Zinc | 1981 |